💡 Uses & Benefits
-
Dual mechanism of action: Linagliptin inhibits DPP‑4 to enhance incretin hormone activity, boosting insulin secretion and lowering glucagon; Metformin reduces liver glucose production and increases insulin sensitivity. Together, they improve glycemic control effectively
-
Convenient dosing: One fixed-dose tablet simplifies treatment compared to taking component drugs separately
-
Flexible dosage adjustment: Can be titrated up to Linagliptin 5 mg/Metformin 1000 mg twice daily, depending on therapeutic needs
-
No renal dose adjustment needed for Linagliptin: Safe even in mild to moderate kidney impairment; Metformin requires caution in severe cases
📋 Product Specifications
| Feature | Details |
|---|---|
| Strength | Linagliptin 2.5 mg + Metformin HCl 850 mg |
| Formulation | Immediate-release oral tablet |
| Manufacturer | Square Pharmaceuticals Ltd., Bangladesh |
| Indication | Adjunct to diet & exercise in adult Type 2 diabetes |
| Dosage | Initial: 2.5 mg/500 mg twice daily; escalate up to 2.5/1000 mg BID or extended-release formulation once daily as needed |
| Typical Price (BD) | ~৳15 per tablet (6-strip ~৳90) |
📌 Highlights at a Glance
-
💊 Two antidiabetic agents in one tablet for comprehensive glycemic control
-
🔄 Oral therapy with flexible doses to match patient needs
-
✅ Safe for mild-to-moderate renal impairment—no dose change needed for Linagliptin
-
🏭 Locally produced by Square Pharma, widely available across Bangladesh
⚠️ Uses & Precautions
-
Take with meals to reduce GI side effects from Metformin
-
Monitor renal and liver function regularly; contraindicated in severe renal dysfunction (eGFR <30) or metabolic acidosis
-
Avoid alcohol and iodinated contrast agents due to risk of lactic acidosis cite turn0search11 turn0search8
-
Common side effects include diarrhea, nausea, nasopharyngitis; hypoglycemia risk increases when used with sulfonylureas or insulin.
-
Cases of acute pancreatitis have been reported—discontinue and evaluate if symptoms appear
-
Drug interactions: Reduced effectiveness with P‑gp/CYP3A4 inducers like rifampin; monitor when using cationic drugs that alter renal transport
🧠 User Advice
-
Start with 2.5 mg Linagliptin/500 mg Metformin twice daily if not already on Metformin, then escalate as needed
-
Encourage diet and exercise to enhance efficacy.
-
Patients should carry fast-acting sugar to manage potential hypoglycemia when used with insulin/SUs.
-
Annual B₁₂ level checks recommended due to potential Metformin-related deficiency cite turn0search8turn0search10
Would you like one of the following next?
-
✅ A consumer-friendly summary for patients or brochures
-
🛒 A bullet-style e‑commerce listing highlighting features
-
📱 A clear health education caption suitable for pharmacy or clinic use
Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
Customer questions & answers
Customer reviews
0 out of 5